USPTO serial 99270198
CERTARA.AI LAYAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 17, 2026
- Examiner
- CHISOLM, KEVON
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CERTARA.AI LAYAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie Webb Olson
Carrie Webb Olson Day Pitney LLPOne Federal Street - 29th FloorBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software to assist with product development, data analysis, and management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for research with dashboard functionality providing grid and graphical visualizations of formatted data allowing users to analyze and visually identify relationships among histopathology, clinical chemistry, and hematology findings in the field of pharmaceutical development; Downloadable computer software in the field of pharmaceutical development facilitating simultaneous analysis of formatted data from multiple studies, data querying, mining and visualization for pharmaceutical research and development using formatted data files as data sources; Downloadable computer software for drug development research; Downloadable software for use in analyzing and integrating biomedical, pharmaceutical, and clinical data; Downloadable software using artificial intelligence and machine learning for predictive modeling, data mining, semantic search, and natural language processing in the fields of drug discovery, development, and regulatory submissions | ACTIVE | Jan 4, 2023 |
| 042 | Scientific research, namely, chemical, biochemical, and molecular analysis, research and testing services in the pharmaceutical, pharmacometrics, drug research, biotechnology and agrochemical industries, and the development and testing of new pharmaceutical products for others; Design of customized cheminformatics software for others; Consultation in the field of computer software and computer hardware design for others; Technological consultation in the field of computer networking; Software as a service (SAAS) services featuring software for data integration; Software as a service (SAAS) services featuring software for creating a network of disparate data; Software as a service (SAAS) services featuring software using artificial intelligence for data integration; Providing online non-downloadable software for data integration; Providing online non-downloadable software for creating networks of disparate data; Providing online non-downloadable software using artificial intelligence for data integration; Providing temporary use of non-downloadable computer software for integrating various databases in the fields of pharmaceuticals, pharmacometrics, drug research and logical data modeling; Providing temporary use of non-downloadable software for the collection, tracking, editing, organizing, analyzing, transmission, storage and sharing of data and information; Platform as a service (PAAS) featuring computer software platforms for predictive data analytics, data modeling and analytics; Providing online non-downloadable software for data input, integration and analytics in the fields of pharmaceuticals, pharmacometrics and drug research; Consultancy in the fields of information technology, pharmacology and software design; Software as a service (SAAS) featuring software for integrating and analyzing structured and unstructured biomedical data using artificial intelligence and machine learning; Providing temporary use of non-downloadable software for semantic search, predictive modeling, and natural language processing in the pharmaceutical, biotechnology, and healthcare industries; Platform as a service (PAAS) featuring computer software platforms for data visualization, data integration, and decision support in pharmaceutical research and development | ACTIVE | Jan 4, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Certara USA, Inc.
- Other trademarks owned by Certara USA, Inc.
- Other trademarks owned by Certara USA, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named CERTARA.AI LAYAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 17, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 17, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 30, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 30, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 30, 2025 | ALIE | ASSIGNED TO LIE | — |
| Nov 25, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 7, 2025 | NWAP | NEW APPLICATION ENTERED | — |